Medicines/finished pharmaceutical products

Reference Number: 
HA421 (a)

Date of prequalification: 
07 March 2008
Basis of listing: 
Prequalified by WHO
Status: 
Active
INN: 
Atazanavir (sulfate)
Therapeutic area: 
HIV/AIDS
Dosage form & strength: 
Capsules, hard 150mg
Storage condition: 
Do not store above 25°C
Shelf life (months): 
24
Packaging: 
Bottle HDPE: 60x1
Applicant: 
Bristol-Myers Squibb Company, P.O. Box 5400, New Jersey, United States of America
FPP Manufacturing Site: 

Astra Zeneca Pharmaceuticals LP, 4601 Highway 62 East, Mount Vernon, Indiana, 47620, United States of America

FPP WHO Public Inspection Reports: 
API Manufacturing Site: 

(Atazanavir (sulfate)) Swords Laboratories , Water Lane, Dublin, Swords County, Ireland

API WHO Public Inspection Reports: